Characterizing the cancer genome in lung adenocarcinoma.

Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, Shah K, Sato M, Thomas RK, Barletta JA, Borecki IB, Broderick S, Chang AC, Chiang DY, Chirieac LR, Cho J, Fujii Y, Gazdar AF, Giordano T, Greulich H, Hanna M, Johnson BE, Kris MG, Lash A, Lin L, Lindeman N, Mardis ER, McPherson JD, Minna JD, Morgan MB, Nadel M, Orringer MB, Osborne JR, Ozenberger B, Ramos AH, Robinson J, Roth JA, Rusch V, Sasaki H, Shepherd F, Sougnez C, Spitz MR, Tsao MS, Twomey D, Verhaak RG, Weinstock GM, Wheeler DA, Winckler W, Yoshizawa A, Yu S, Zakowski MF, Zhang Q, Beer DG, Wistuba II, Watson MA, Garraway LA, Ladanyi M, Travis WD, Pao W, Rubin MA, Gabriel SB, Gibbs RA, Varmus HE, Wilson RK, Lander ES, Meyerson M
Nature. 2007 450 (7171): 893-8

PMID: 17982442 · PMCID: PMC2538683 · DOI:10.1038/nature06358

MeSH Terms (19)

Adenocarcinoma Cell Line, Tumor Chromosome Deletion Chromosomes, Human, Pair 14 Gene Amplification Genome, Human Genomics Genomics Genotype Humans Intracellular Signaling Peptides and Proteins Loss of Heterozygosity Lung Neoplasms Neoplasms Nuclear Proteins Polymorphism, Single Nucleotide RNA Interference Thyroid Nuclear Factor 1 Transcription Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links